Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Ludwig-Maximilians - University of Munich Santen Gmbh |
---|---|
Information provided by: | Ludwig-Maximilians - University of Munich |
ClinicalTrials.gov Identifier: | NCT00491049 |
The purpose of this study is to determine whether additional topical application of 0.5% levofloxacin is more effective in reducing the load of the conjunctival bacterial flora in patients scheduled for intraocular surgery than preoperative irrigation of the conjunctiva with povidone iodine alone.
Condition | Intervention | Phase |
---|---|---|
Conjunctival Bacterial Flora |
Drug: 0.5% levofloxacin eye drops |
Phase IV |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Phase 4 Study on Effectiveness of Topical 0.5% Levofloxacin on Reduction of Preoperative Conjunctival Flora in Patients Scheduled for Intraocular Surgery |
Enrollment: | 140 |
Study Start Date: | September 2004 |
Study Completion Date: | April 2005 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Germany, Bavaria | |
Augenklinik der LMU | |
Munich, Bavaria, Germany, 80336 |
Principal Investigator: | Herminia Mino de Kapsar, PhD | Augenklinik der LMU |
Study ID Numbers: | LevoProMUC03 |
Study First Received: | June 21, 2007 |
Last Updated: | June 21, 2007 |
ClinicalTrials.gov Identifier: | NCT00491049 |
Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
prophylaxis intraocular surgery endophthalmitis antibiotic |
Ofloxacin Endophthalmitis Tetrahydrozoline |
Anti-Infective Agents Anti-Bacterial Agents Molecular Mechanisms of Pharmacological Action Therapeutic Uses Anti-Infective Agents, Urinary |
Enzyme Inhibitors Renal Agents Nucleic Acid Synthesis Inhibitors Pharmacologic Actions |